StonvexLoading…
StonvexStonvexStonvexCore line items from MYE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-29 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $167.66M | $164.58M | $825.74M | $621.77M | $416.33M |
Operating Income | Not available | $24.85M | $74.56M | $54.32M | $36.63M |
Net Income | Not available | $-1.83M | $34.93M | $23.60M | $16.51M |
EPS (Diluted) | $0.32 | $-0.05 | $0.93 | $0.63 | $0.44 |
Total Assets | Not available | $836.73M | $852.58M | $864.07M | $862.71M |
Total Liabilities | Not available | $547.86M | $558.35M | $577.45M | $578.07M |
Cash & Equivalents | Not available | $44.59M | $40.51M | $47.97M | $41.29M |
Free Cash Flow OCF − CapEx | Not available | $23.43M | $67.21M | $48.27M | $26.75M |
Shares Outstanding | Not available | 37.47M | 37.38M | 37.39M | 37.38M |